Cargando…

Determinants of HIV-1 Late Presentation in Patients Followed in Europe

To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm(3) or an AIDS-defini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda, Mafalda N. S., Pingarilho, Marta, Pimentel, Victor, Martins, Maria do Rosário O., Vandamme, Anne-Mieke, Bobkova, Marina, Böhm, Michael, Seguin-Devaux, Carole, Paredes, Roger, Rubio, Rafael, Zazzi, Maurizio, Incardona, Francesca, Abecasis, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308660/ https://www.ncbi.nlm.nih.gov/pubmed/34357985 http://dx.doi.org/10.3390/pathogens10070835

Ejemplares similares

Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late Presenters
por: Miranda, Mafalda N. S., et al.
Publicado: (2022)

Retention in Care and Virological Failure among Adult HIV-Positive Patients on First-Line Antiretroviral Treatment in Maputo, Mozambique
por: Joaquim, Leonid, et al.
Publicado: (2023)

Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations
por: Pingarilho, Marta, et al.
Publicado: (2020)

Molecular Epidemiology of HIV-1 Infected Migrants Followed Up in Portugal: Trends between 2001–2017
por: Pimentel, Victor, et al.
Publicado: (2020)

Pre‐existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first‐line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus‐infected patients
por: Kuznetsova, Anna, et al.
Publicado: (2022)

A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2
por: Miranda, Mafalda N. S., et al.
Publicado: (2022)

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022)

Molecular Epidemiology of HIV-1 in Eastern Europe and Russia
por: van de Klundert, Maarten A. A., et al.
Publicado: (2022)

Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey
por: De Luca, Andrea, et al.
Publicado: (2019)

Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort
por: Bartha, István, et al.
Publicado: (2013)

Bridging epidemiology with population genetics in a low incidence MSM-driven HIV-1 subtype B epidemic in Central Europe
por: Lunar, Maja M, et al.
Publicado: (2015)

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium
por: Vinken, Lore, et al.
Publicado: (2019)

The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds
por: Pironti, A, et al.
Publicado: (2010)

Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time
por: Frentz, Dineke, et al.
Publicado: (2010)

Genome-wide diversity of Zika virus: Exploring spatio-temporal dynamics to guide a new nomenclature proposal
por: Seabra, Sofia G, et al.
Publicado: (2022)

Characterization of a large cluster of HIV-1 A1 infections detected in Portugal and connected to several Western European countries
por: Araújo, Pedro M. M., et al.
Publicado: (2019)

Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy
por: Svärd, Jenny, et al.
Publicado: (2017)

Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network)
por: Rossetti, Barbara, et al.
Publicado: (2023)

PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context
por: Libin, Pieter, et al.
Publicado: (2017)

European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection
por: Raimondi, Sara, et al.
Publicado: (2023)

Correction: European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection
por: Raimondi, Sara, et al.
Publicado: (2023)

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group
por: Frentz, Dineke, et al.
Publicado: (2014)

Phylogeography of hepatitis B virus: The role of Portugal in the early dissemination of HBV worldwide
por: Marcelino, Rute, et al.
Publicado: (2022)

Zika genomics urgently need standardized and curated reference sequences
por: Theys, Kristof, et al.
Publicado: (2017)

Only Slight Impact of Predicted Replicative Capacity for Therapy Response Prediction
por: Weisser, Hendrik, et al.
Publicado: (2010)

Dengue importation into Europe: A network connectivity-based approach
por: Salami, Donald, et al.
Publicado: (2020)

Limited cross-border infections in patients newly diagnosed with HIV in Europe
por: Frentz, Dineke, et al.
Publicado: (2013)

Predicting dengue importation into Europe, using machine learning and model-agnostic methods
por: Salami, Donald, et al.
Publicado: (2020)

Correction: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models
por: Prosperi, Mattia C. F., et al.
Publicado: (2011)

Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models
por: Prosperi, Mattia C. F., et al.
Publicado: (2010)

HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments
por: Ho, Yung Shwen, et al.
Publicado: (2008)

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
por: Abecasis, Ana B, et al.
Publicado: (2013)

The characteristics of the HIV subtype B epidemic in Slovenia
por: Lunar, Maja M, et al.
Publicado: (2014)

Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance Mutations
por: Theys, Kristof, et al.
Publicado: (2016)

Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals
por: Winand, Raf, et al.
Publicado: (2015)

HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia
por: Schlösser, Madita, et al.
Publicado: (2020)

Selecting anti-HIV therapies based on a variety of genomic and clinical factors
por: Rosen-Zvi, Michal, et al.
Publicado: (2008)

Drivers of HIV-1 transmission: The Portuguese case
por: Pineda-Peña, Andrea-Clemencia, et al.
Publicado: (2019)

Interplay Between Transmitted and Acquired HIV Type 1 Drug Resistance: Reasons for a Disconnect
por: De Luca, Andrea, et al.
Publicado: (2015)

Determinants of Late HIV Presentation at Ndlavela Health Center in Mozambique
por: Chone, Jeremias Salomão, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5atdrt5pl12crmrvchp5ultfn